Avita Medical (NASDAQ:RCEL – Free Report) had its price objective cut by Lake Street Capital from $14.00 to $8.00 in a research note issued to investors on Monday morning,Benzinga reports. They currently have a buy rating on the stock.
A number of ot… [3637 chars]
Lake Street Capital Cuts Avita Medical (NASDAQ:RCEL) Price Target to $8.00
